Skip to content
Metaboliq
Menu

Insulin resistance

The fasting insulin test, and why it is missing from your report

Almost every annual health package in India measures fasting glucose. Very few measure fasting insulin. The difference between the two is the difference between knowing the answer and knowing how hard the body is working to produce it.

Not yet reviewed by a clinician

Nobody has signed this page off, so no name and no registration number are shown. We would rather say that than print one you cannot check. Every source below is named and linked in the meantime, so you can read them and disagree with us. The standard a reviewed page is held to is set out on our review standard page.

Published 15 August 2026 · Last updated 15 August 2026

Part of Insulin resistance.

What the test actually measures

Insulin is a signalling hormone. After a meal the pancreas releases it, and it instructs muscle, liver and fat cells to take glucose out of the blood. A fasting insulin test measures how much of that signal is circulating after eight to twelve hours without food — that is, how much instruction the body needs simply to hold a resting glucose level steady, before any meal has arrived to complicate the picture.

That framing matters, because glucose is an outcome and insulin is an effort. Two people can have precisely the same fasting glucose reading with very different amounts of insulin behind it, and the one needing more insulin to produce the same reading is doing more work for the same result. The test is cheap, it is widely available in Indian laboratories, and it is almost never included in a standard corporate health check.

Sources: [2]

Why a normal sugar report does not settle the question

The pancreas compensates. When cells respond less to insulin, beta cells raise output, and for as long as they can raise it enough the glucose reading stays where it always was. The compensation has been documented directly: insulin secretion rises in proportion to the fall in sensitivity, which is exactly why the earliest phase of the problem is invisible to a test that only looks at glucose.

This is the single most useful thing to understand about a reassuring annual report. A normal fasting sugar means the system is currently succeeding. It does not describe the price being paid for that success, and it is entirely compatible with a substantial change in insulin having already occurred.

Sources: [2], [5]

How long that compensating phase lasts, and whether it always progresses, varies enormously between individuals. Nobody can read a duration off a single blood sample.

There is no single number that means 'high'

This is where most articles on the subject overstate. Fasting insulin has no internationally agreed diagnostic threshold in the way fasting glucose does. Insulin assays are not standardised between manufacturers, so a value from one laboratory is not strictly interchangeable with a value from another, and reference intervals printed on a report are the interval that laboratory derived from its own population and its own kit.

The people who built the most widely used index from this measurement said as much themselves, in a paper specifically about how their model gets misapplied: assay variation and population differences mean a universal cut-off does not exist, and the number is most useful compared against itself over time, or read alongside the rest of a panel, rather than compared against a line from the internet.

Sources: [3], [1]

How to prepare, so the result is worth having

A genuine fast is required — typically eight to twelve hours, water permitted. Tea with sugar, a biscuit with morning medicine, or a chewing gum on the way to the collection all raise insulin, and because insulin responds faster and more sharply than glucose, a small lapse distorts this test more than it distorts the one next to it on the same form.

Two other practical points. Take the sample in the morning rather than after a day of fasting, because a very long fast pushes the result in the other direction. And if a home collection is being done, the sample needs to reach the laboratory promptly; insulin is less robust in a poorly handled tube than glucose is, which is one reason it is worth asking who is collecting and how far the sample travels.

Sources: [3]

What it is read alongside

On its own, fasting insulin is a curiosity. Read with fasting glucose it yields a sensitivity index. Read with HbA1c it distinguishes a body that is compensating well from one that has started to lose ground. Read with a lipid panel, liver markers, thyroid function and a waist measurement, it becomes part of a description of how one person's metabolism is behaving rather than an isolated figure to worry about.

That combination is also the reason interpretation is a clinical job rather than an arithmetic one. The same insulin value carries a different weight in a twenty-six-year-old with irregular cycles, a fifty-year-old with a family history of diabetes, and someone who has been unwell in the fortnight before the sample was taken. The number does not change; what it is evidence of does.

Sources: [1], [4]

Why it is worth asking for in India specifically

The national picture makes the case. India's largest cross-sectional survey of metabolic disease found prediabetes and abdominal obesity at a scale that standard packages are not designed to detect early, with a substantial share of it undiagnosed at the point the survey reached people. A test that describes the compensating phase — before glucose has moved — is precisely the test that a population with that profile is under-using.

None of which means everyone needs it tomorrow. It means that if the question in your head is why the same food and the same effort produce a different result for you than for the people you eat with, fasting glucose alone was never going to answer it, and adding one inexpensive marker to the form changes what the conversation with a doctor can be about.

Sources: [4]

Where this comes from

Every source, in full

Linked to the publisher or to the abstract, so you can read them and disagree with us.

  1. [1] Matthews DR, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man

    Diabetologia, 1985. Describes the model that estimates insulin sensitivity and beta-cell function from a single fasting glucose and fasting insulin pair — the arithmetic behind HOMA-IR.

    Read the source
  2. [2] Ferrannini E, Natali A, et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR)

    Journal of Clinical Investigation, 1997. Insulin secretion rises to compensate for reduced sensitivity, which is why glucose can remain in the usual range for years while insulin output has already changed substantially.

    Read the source
  3. [3] Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling

    Diabetes Care, 2004. The model's own authors set out where the index is valid and where it is misapplied, including the absence of a universal cut-off and the effect of assay variation between laboratories.

    Read the source
  4. [4] Anjana RM, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)

    The Lancet Diabetes & Endocrinology, 2023. The national survey of diabetes, prediabetes, abdominal obesity and dyslipidaemia across Indian states, and the scale of prediabetes that had not been diagnosed at the time of survey.

    Read the source
  5. [5] Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes

    The Lancet, 2017. A general review of type 2 diabetes: the long asymptomatic phase before diagnosis, and the progressive nature of the underlying changes in insulin secretion and sensitivity.

    Read the source

One next step

Health assessment

Fasting insulin is only informative next to the glucose, lipid, thyroid and liver markers it is meant to be read with, and by somebody registered to read them together.

₹1,799blood_panel_45_markers, home_collection, doctor_review, eligibility_decision, personalised_plan_day_3. Provided by Metaboliq with a partnered NABL-accredited laboratory.

Related reading

These answer the question next to this one

Because almost nobody arrives with exactly one question.